Adage Capital Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.9M Sell
105,657
-98,936
-48% -$32.5M 0.05% 361
2025
Q4
$71.7M Buy
204,593
+33,145
+19% +$11.2M 0.11% 182
2025
Q3
$55.4M Buy
171,448
+82,272
+92% +$25.6M 0.09% 217
2025
Q2
$34.7M Sell
89,176
-16,987
-16% -$6.83M 0.06% 311
2025
Q1
$46.2M Buy
106,163
+9,534
+10% +$3.83M 0.09% 242
2024
Q4
$35.6M Sell
96,629
-50,428
-34% -$21.1M 0.06% 285
2024
Q3
$76.5M Sell
147,057
-98,490
-40% -$52.6M 0.14% 150
2024
Q2
$133M Sell
245,547
-28,429
-10% -$15M 0.25% 75
2024
Q1
$142M Buy
273,976
+105,109
+62% +$52.3M 0.27% 70
2023
Q4
$79.6M Sell
168,867
-39,553
-19% -$18.3M 0.16% 140
2023
Q3
$90.8M Sell
208,420
-12,563
-6% -$5.7M 0.21% 118
2023
Q2
$98.2M Sell
220,983
-37,165
-14% -$17.1M 0.21% 115
2023
Q1
$119M Buy
258,148
+15,255
+6% +$7.26M 0.27% 91
2022
Q4
$125M Sell
242,893
-1,600
-0.7% -$812K 0.3% 74
2022
Q3
$111M Sell
244,493
-6,600
-3% -$3.16M 0.28% 77
2022
Q2
$121M Sell
251,093
-2,400
-0.9% -$1.19M 0.28% 71
2022
Q1
$125M Sell
253,493
-5,100
-2% -$2.33M 0.24% 91
2021
Q4
$120M Sell
258,593
-3,900
-1% -$1.64M 0.22% 102
2021
Q3
$97.9M Sell
262,493
-3,700
-1% -$1.41M 0.19% 111
2021
Q2
$102M Sell
266,193
-6,400
-2% -$2.45M 0.2% 105
2021
Q1
$97.8M Sell
272,593
-3,500
-1% -$1.13M 0.2% 116
2020
Q4
$88.7M Sell
276,093
-6,300
-2% -$1.93M 0.19% 116
2020
Q3
$75.8M Sell
282,393
-9,500
-3% -$2.56M 0.19% 118
2020
Q2
$76.8M Buy
291,893
+2,700
+0.9% +$720K 0.2% 122
2020
Q1
$65.7M Sell
289,193
-5,900
-2% -$1.61M 0.2% 127
2019
Q4
$89.1M Sell
295,093
-16,500
-5% -$4.54M 0.22% 123
2019
Q3
$74.8M Sell
311,593
-2,900
-0.9% -$795K 0.18% 144
2019
Q2
$88.8M Sell
314,493
-6,700
-2% -$1.83M 0.22% 118
2019
Q1
$92.2M Sell
321,193
-100
-0% -$28.9K 0.23% 112
2018
Q4
$84.4M Sell
321,293
-15,300
-5% -$4.21M 0.23% 123
2018
Q3
$92.2M Buy
336,593
+40,500
+14% +$10.5M 0.21% 123
2018
Q2
$70.5M Buy
296,093
+70,400
+31% +$16.3M 0.16% 167
2018
Q1
$49.6M Sell
225,693
-19,700
-8% -$4.63M 0.12% 223
2017
Q4
$55.2M Sell
245,393
-135,000
-35% -$28.8M 0.12% 209
2017
Q3
$72.2M Sell
380,393
-101,500
-21% -$19.3M 0.18% 163
2017
Q2
$90.7M Buy
481,893
+2,600
+0.5% +$467K 0.22% 132
2017
Q1
$79.3M Buy
479,293
+2,700
+0.6% +$429K 0.2% 143
2016
Q4
$68.5M Buy
476,593
+169,800
+55% +$22.7M 0.19% 150
2016
Q3
$38.4M Sell
306,793
-8,000
-3% -$1.03M 0.11% 259
2016
Q2
$41.3M Buy
314,793
+116,015
+58% +$15.9M 0.11% 219
2016
Q1
$27.6M Buy
198,778
+152,390
+329% +$20.4M 0.07% 288
2015
Q4
$6.47M Buy
+46,388
New +$6.39M 0.02% 581
2015
Q3
Sell
-531,106
Closed -$87.2M 724
2015
Q2
$87.2M Buy
531,106
+48,000
+10% +$7.67M 0.22% 131
2015
Q1
$74.6M Sell
483,106
-13,000
-3% -$1.85M 0.18% 161
2014
Q4
$62.3M Sell
496,106
-46,200
-9% -$5.71M 0.15% 185
2014
Q3
$64.9M Buy
542,306
+14,100
+3% +$1.62M 0.16% 176
2014
Q2
$56.8M Buy
528,206
+205,000
+63% +$21.1M 0.15% 190
2014
Q1
$32.2M Sell
323,206
-17,300
-5% -$1.56M 0.09% 274
2013
Q4
$31.5M Sell
340,506
-42,000
-11% -$3.73M 0.08% 306
2013
Q3
$32M Sell
382,506
-260,000
-40% -$22.3M 0.09% 271
2013
Q2
$52.6M Buy
+642,506
New +$48.1M 0.16% 172

Other funds holding ELV

Adage Capital Partners's ELV Position: Q1 2026 in Review

Adage Capital Partners reduced its Elevance Health (ELV) stake by 48% in Q1 2026, selling an estimated $32.5M and leaving 105,657 shares worth $30.9M. The position accounts for 0.05% of the portfolio, ranked #361.

Adage Capital Partners first reported a position in ELV in Q2 2013 and has held it in 51 quarters since. The position peaked at $142M in Q1 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Adage Capital Partners held 105,657 shares of Elevance Health worth $30.9M as of Q1 2026.
  • Adage Capital Partners sold 98,936 Elevance Health shares in Q1 2026, an estimated $32.5M.
  • Elevance Health made up 0.05% of Adage Capital Partners's portfolio in Q1 2026, its #361 holding.
  • Adage Capital Partners first reported a position in Elevance Health in Q2 2013 and has held it in 51 quarters since.
  • Adage Capital Partners's Elevance Health position peaked at $142M in Q1 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.